{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T18:01:15Z","timestamp":1773338475579,"version":"3.50.1"},"reference-count":230,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["2023-02312"],"award-info":[{"award-number":["2023-02312"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014438","name":"Business Finland","doi-asserted-by":"publisher","award":["6690\/31\/2023"],"award-info":[{"award-number":["6690\/31\/2023"]}],"id":[{"id":"10.13039\/501100014438","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.pharmthera.2025.108944","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T02:14:48Z","timestamp":1761617688000},"page":"108944","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Animal models in leukotriene research: Current insights into complex pathways and therapeutic intervention"],"prefix":"10.1016","volume":"276","author":[{"given":"Tarvi","family":"Teder","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olof","family":"R\u00e5dmark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesper Z.","family":"Haeggstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helike","family":"L\u00f5helaid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"46","key":"10.1016\/j.pharmthera.2025.108944_bb0005","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adf8764","article-title":"Leukotriene A4 hydrolase inhibition improves age-related cognitive decline via modulation of synaptic function","volume":"9","author":"Adams","year":"2023","journal-title":"Science Advances"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108944_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbalip.2015.10.001","article-title":"The lipoxygenase pathway in zebrafish. Expression and characterization of zebrafish ALOX5 and comparison with its human ortholog","volume":"1861","author":"Adel","year":"2016","journal-title":"Biochimica et Biophysica Acta"},{"issue":"11","key":"10.1016\/j.pharmthera.2025.108944_bb0015","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1042\/CS20200394","article-title":"Back to the future: re-establishing guinea pig in vivo asthma models","volume":"134","author":"Adner","year":"2020","journal-title":"Clinical Science (London, England)"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108944_bb0020","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/0006-291X(85)91323-3","article-title":"In vitro metabolism of [3H]-peptide leukotrienes in human and ferret lung: a comparison with the guinea pig","volume":"131","author":"Aharony","year":"1985","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.pharmthera.2025.108944_bb0025","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.853000","article-title":"Brain-specific increase in leukotriene signaling accompanies chronic neuroinflammation and cognitive impairment in a model of Gulf war illness","volume":"13","author":"Attaluri","year":"2022","journal-title":"Frontiers in Immunology"},{"issue":"7","key":"10.1016\/j.pharmthera.2025.108944_bb0030","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1080\/07853890600982737","article-title":"Leukotriene receptors in atherosclerosis","volume":"38","author":"B\u00e4ck","year":"2006","journal-title":"Annals of Medicine"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108944_bb0035","doi-asserted-by":"crossref","first-page":"H419","DOI":"10.1152\/ajpheart.00699.2003","article-title":"Leukotriene B4 is an indirectly acting vasoconstrictor in guinea pig aorta via an inducible type of BLT receptor","volume":"287","author":"B\u00e4ck","year":"2004","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"issue":"12","key":"10.1016\/j.pharmthera.2025.108944_bb0040","doi-asserted-by":"crossref","first-page":"5221","DOI":"10.4049\/jimmunol.157.12.5221","article-title":"Leukotriene-deficient mice manifest enhanced lethality from Klebsiella pneumonia in association with decreased alveolar macrophage phagocytic and bactericidal activities","volume":"157","author":"Bailie","year":"1996","journal-title":"Journal of Immunology"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108944_bb0045","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.pupt.2014.06.003","article-title":"Effects of JNJ-40929837, a leukotriene A4 hydrolase inhibitor, in a bronchial allergen challenge model of asthma","volume":"29","author":"Barchuk","year":"2014","journal-title":"Pulmonary Pharmacology & Therapeutics"},{"issue":"44","key":"10.1016\/j.pharmthera.2025.108944_bb0050","doi-asserted-by":"crossref","first-page":"46129","DOI":"10.1074\/jbc.M407057200","article-title":"Targeted gene disruption reveals the role of the cysteinyl leukotriene 2 receptor in increased vascular permeability and in bleomycin-induced pulmonary fibrosis in mice","volume":"279","author":"Beller","year":"2004","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2025.108944_bb0055","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.smim.2017.08.007","article-title":"Recent advances in clinical development of leukotriene B4 pathway drugs","volume":"33","author":"Bhatt","year":"2017","journal-title":"Seminars in Immunology"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108944_bb0060","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s12079-020-00585-0","article-title":"A review of prostanoid receptors: Expression, characterization, regulation, and mechanism of action","volume":"15","author":"Biringer","year":"2021","journal-title":"Journal of Cell Communication and Signaling"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108944_bb0065","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/BF00916243","article-title":"Increase in vascular permeability induced by leukotriene B4 and the role of polymorphonuclear leukocytes","volume":"6","author":"Bj\u00f6rk","year":"1982","journal-title":"Inflammation"},{"issue":"5","key":"10.1016\/j.pharmthera.2025.108944_bb0070","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.4049\/jimmunol.1003473","article-title":"5-lipoxygenase-deficient mice infected with Borrelia burgdorferi develop persistent arthritis","volume":"186","author":"Blaho","year":"2011","journal-title":"Journal of Immunology"},{"issue":"3","key":"10.1016\/j.pharmthera.2025.108944_bb0075","doi-asserted-by":"crossref","first-page":"235","DOI":"10.5326\/15473317-33-3-235","article-title":"The effects of varying dietary n-6 to n-3 fatty acid ratios on platelet reactivity, coagulation screening assays, and antithrombin III activity in dogs","volume":"33","author":"Boudreaux","year":"1997","journal-title":"Journal of the American Animal Hospital Association"},{"issue":"6","key":"10.1016\/j.pharmthera.2025.108944_bb0080","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1177\/10915818221125670","article-title":"The dog as a second species for toxicology testing provides value to drug development","volume":"41","author":"Bower","year":"2022","journal-title":"International Journal of Toxicology"},{"issue":"6","key":"10.1016\/j.pharmthera.2025.108944_bb0085","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1084\/jem.185.6.1065","article-title":"Role of the 5-lipoxygenase-activating protein (FLAP) in murine acute inflammatory responses","volume":"185","author":"Byrum","year":"1997","journal-title":"Journal of Experimental Medicine"},{"issue":"12","key":"10.1016\/j.pharmthera.2025.108944_bb0090","doi-asserted-by":"crossref","first-page":"6810","DOI":"10.4049\/jimmunol.163.12.6810","article-title":"Determination of the contribution of cysteinyl leukotrienes and leukotriene B4 in acute inflammatory responses using 5-lipoxygenase- and leukotriene A4 hydrolase-deficient mice","volume":"163","author":"Byrum","year":"1999","journal-title":"Journal of Immunology"},{"issue":"825","key":"10.1016\/j.pharmthera.2025.108944_bb0095","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.adh1178","article-title":"ALOX5 drives the pyroptosis of CD4(+) T cells and tissue inflammation in rheumatoid arthritis","volume":"17","author":"Cai","year":"2024","journal-title":"Science Signaling"},{"issue":"3","key":"10.1016\/j.pharmthera.2025.108944_bb0100","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1042\/EBC20190083","article-title":"Eicosanoids","volume":"64","author":"Calder","year":"2020","journal-title":"Essays in Biochemistry"},{"issue":"2\u20133","key":"10.1016\/j.pharmthera.2025.108944_bb0105","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0014-2999(98)00262-3","article-title":"Effects of MK-886, a leukotriene biosynthesis inhibitor, in a rabbit model of endotoxic shock","volume":"350","author":"Can","year":"1998","journal-title":"European Journal of Pharmacology"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108944_bb0110","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.atherosclerosis.2008.07.045","article-title":"Genetic and pharmacological inhibition of the 5-lipoxygenase\/leukotriene pathway in atherosclerotic lesion development in ApoE deficient mice","volume":"203","author":"Cao","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.pharmthera.2025.108944_bb0115","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2023.1099719","article-title":"Advances in respiratory physiology in mouse models of experimental asthma","volume":"14","author":"Carroll","year":"2023","journal-title":"Frontiers in Physiology"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108944_bb0120","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.pupt.2013.11.007","article-title":"Effects of a FLAP inhibitor, GSK2190915, in asthmatics with high sputum neutrophils","volume":"27","author":"Chaudhuri","year":"2014","journal-title":"Pulmonary Pharmacology & Therapeutics"},{"issue":"5","key":"10.1016\/j.pharmthera.2025.108944_bb0125","doi-asserted-by":"crossref","first-page":"6634","DOI":"10.18632\/aging.202501","article-title":"CRISPR\/Cas9-mediated CysLT1R deletion reverses synaptic failure, amyloidosis and cognitive impairment in APP\/PS1 mice","volume":"13","author":"Chen","year":"2021","journal-title":"Aging (Albany NY)"},{"issue":"4","key":"10.1016\/j.pharmthera.2025.108944_bb0130","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1084\/jem.20052371","article-title":"Neutrophil-derived leukotriene B4 is required for inflammatory arthritis","volume":"203","author":"Chen","year":"2006","journal-title":"The Journal of Experimental Medicine"},{"issue":"6502","key":"10.1016\/j.pharmthera.2025.108944_bb0135","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/372179a0","article-title":"Role of leukotrienes revealed by targeted disruption of the 5-lipoxygenase gene","volume":"372","author":"Chen","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2025.108944_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2024.105729","article-title":"Opportunities and challenges for use of minipigs in nonclinical pharmaceutical development: Results of a follow-up IQ DruSafe survey","volume":"154","author":"Clarke","year":"2024","journal-title":"Regulatory Toxicology and Pharmacology"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108944_bb0145","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/bph.15721","article-title":"Targeting the OXE receptor with a selective antagonist inhibits allergen-induced pulmonary inflammation in non-human primates","volume":"179","author":"Cossette","year":"2022","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2025.108944_bb0150","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1219160","article-title":"Differential impact of 5-lipoxygenase-activating protein antagonists on the biosynthesis of leukotrienes and of specialized pro-resolving mediators","volume":"14","author":"Dahlke","year":"2023","journal-title":"Frontiers in Pharmacology"},{"issue":"33","key":"10.1016\/j.pharmthera.2025.108944_bb0155","doi-asserted-by":"crossref","first-page":"15601","DOI":"10.1016\/S0021-9258(18)66757-2","article-title":"Metabolism and analysis of cysteinyl leukotrienes in the monkey","volume":"261","author":"Denzlinger","year":"1986","journal-title":"The Journal of Biological Chemistry"},{"issue":"4723","key":"10.1016\/j.pharmthera.2025.108944_bb0160","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1126\/science.4048937","article-title":"Leukotrienes as mediators in tissue trauma","volume":"230","author":"Denzlinger","year":"1985","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.pharmthera.2025.108944_bb0165","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.2174\/138945012802009053","article-title":"Leukotriene C4 synthase: upcoming drug target for inflammation","volume":"13","author":"Devi","year":"2012","journal-title":"Current Drug Targets"},{"issue":"3","key":"10.1016\/j.pharmthera.2025.108944_bb0170","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/S0006-291X(87)80199-7","article-title":"Platelet activating factor-mediated leukotriene biosynthesis in rat lungs: effect of prostaglandins E1 and F1a","volume":"147","author":"Di Marzo","year":"1987","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.pharmthera.2025.108944_bb0175","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/1743-7075-7-89","article-title":"Use of hamster as a model to study diet-induced atherosclerosis","volume":"7","author":"Dillard","year":"2010","journal-title":"Nutrition & Metabolism (London)"},{"issue":"12","key":"10.1016\/j.pharmthera.2025.108944_bb0180","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1161\/01.RES.0000194321.60300.d6","article-title":"TRPV4 forms a novel Ca2+ signaling complex with ryanodine receptors and BKCa channels","volume":"97","author":"Earley","year":"2005","journal-title":"Circulation Research"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108944_bb0185","doi-asserted-by":"crossref","first-page":"L292","DOI":"10.1152\/ajplung.00120.2016","article-title":"Leukotriene B4 mediates macrophage influx and pulmonary hypertension in bleomycin-induced chronic neonatal lung injury","volume":"311","author":"Ee","year":"2016","journal-title":"American Journal of Physiology. Lung Cellular and Molecular Physiology"},{"issue":"6","key":"10.1016\/j.pharmthera.2025.108944_bb0190","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/BF00914313","article-title":"Leukotriene B4-induced permeability increase in postcapillary venules and its inhibition by three different antiinflammatory drugs","volume":"13","author":"Erlansson","year":"1989","journal-title":"Inflammation"},{"key":"10.1016\/j.pharmthera.2025.108944_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.tvjl.2024.106210","article-title":"Exploring montelukast in dogs: A preliminary pharmacokinetic study following oral administration under fasted and fed conditions","volume":"307","author":"Fadel","year":"2024","journal-title":"Veterinary Journal"},{"issue":"11","key":"10.1016\/j.pharmthera.2025.108944_bb0200","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1089\/neu.2009.0877","article-title":"Injury-related production of cysteinyl leukotrienes contributes to brain damage following experimental traumatic brain injury","volume":"26","author":"Farias","year":"2009","journal-title":"Journal of Neurotrauma"},{"issue":"6","key":"10.1016\/j.pharmthera.2025.108944_bb0205","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.3892\/ijmm.2012.1142","article-title":"GPR40: a therapeutic target for mediating insulin secretion (review)","volume":"30","author":"Feng","year":"2012","journal-title":"International Journal of Molecular Medicine"},{"issue":"6","key":"10.1016\/j.pharmthera.2025.108944_bb0210","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/sj.embor.7400993","article-title":"The ethics of animal research","volume":"8","author":"Festing","year":"2007","journal-title":"EMBO Reports"},{"issue":"8","key":"10.1016\/j.pharmthera.2025.108944_bb0215","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1164\/rccm.200201-055OC","article-title":"Neurokinins modulate hyperventilation-induced bronchoconstriction in canine peripheral airways","volume":"167","author":"Freed","year":"2003","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"11","key":"10.1016\/j.pharmthera.2025.108944_bb0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0277307","article-title":"Cysteinyl leukotriene receptor 1 is dispensable for osteoclast differentiation and bone resorption","volume":"17","author":"Fujita","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2025.108944_bb0225","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1126\/science.294.5548.1871","article-title":"Prostaglandins and leukotrienes: Advances in eicosanoid biology","volume":"294","author":"Funk","year":"2001","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.pharmthera.2025.108944_bb0230","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1164\/ajrccm.160.4.9812042","article-title":"Crucial role of group IIA phospholipase A2 in oleic acid-induced acute lung injury in rabbits","volume":"160","author":"Furue","year":"1999","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"11","key":"10.1016\/j.pharmthera.2025.108944_bb0235","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1161\/CIRCRESAHA.116.310525","article-title":"20-HETE signals through G-protein-coupled receptor GPR75 (G(q)) to affect vascular function and trigger hypertension","volume":"120","author":"Garcia","year":"2017","journal-title":"Circulation Research"},{"issue":"4","key":"10.1016\/j.pharmthera.2025.108944_bb0240","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1084\/jem.183.4.1893","article-title":"Inhibition of leukotriene B4-receptor interaction suppresses eosinophil infiltration and disease pathology in a murine model of experimental allergic encephalomyelitis","volume":"183","author":"Gladue","year":"1996","journal-title":"The Journal of Experimental Medicine"},{"issue":"3","key":"10.1016\/j.pharmthera.2025.108944_bb0245","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1152\/jappl.1988.64.3.936","article-title":"Effects of cyclo- and lipoxygenase inhibitors on hypoxic vasoconstriction in isolated ferret lungs","volume":"64","author":"Gottlieb","year":"1988","journal-title":"Journal of Applied Physiology"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108944_bb0250","doi-asserted-by":"crossref","first-page":"359","DOI":"10.4049\/jimmunol.163.1.359","article-title":"Deficiency of 5-lipoxygenase abolishes sex-related survival differences in MRL-lpr\/lpr mice","volume":"163","author":"Goulet","year":"1999","journal-title":"Journal of Immunology"},{"issue":"26","key":"10.1016\/j.pharmthera.2025.108944_bb0255","doi-asserted-by":"crossref","first-page":"12852","DOI":"10.1073\/pnas.91.26.12852","article-title":"Altered inflammatory responses in leukotriene-deficient mice","volume":"91","author":"Goulet","year":"1994","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108944_bb0260","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1073\/pnas.92.2.517","article-title":"Leukotriene B4 plays a critical role in the progression of collagen-induced arthritis","volume":"92","author":"Griffiths","year":"1995","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2025.108944_bb0265","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jare.2024.07.018","article-title":"CRISPR\/Cas9-mediated neuronal deletion of 5-lipoxygenase alleviates deficits in mouse models of epilepsy","volume":"63","author":"Guan","year":"2024","journal-title":"Journal of Advanced Research"},{"key":"10.1016\/j.pharmthera.2025.108944_bb0270","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.imlet.2018.11.012","article-title":"Mouse models of severe asthma for evaluation of therapeutic cytokine targeting","volume":"207","author":"Gubernatorova","year":"2019","journal-title":"Immunology Letters"},{"key":"10.1016\/j.pharmthera.2025.108944_bb0275","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ejmech.2017.07.019","article-title":"Drug discovery approaches targeting 5-lipoxygenase-activating protein (FLAP) for inhibition of cellular leukotriene biosynthesis","volume":"153","author":"G\u00fcr","year":"2018","journal-title":"European Journal of Medicinal Chemistry"},{"issue":"7","key":"10.1016\/j.pharmthera.2025.108944_bb0280","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1172\/JCI97945","article-title":"Leukotriene biosynthetic enzymes as therapeutic targets","volume":"128","author":"Haeggstr\u00f6m","year":"2018","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2025.108944_bb0285","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1146\/annurev-pharmtox-051921-085014","article-title":"Structures of leukotriene biosynthetic enzymes and development of new therapeutics","volume":"63","author":"Haeggstr\u00f6m","year":"2022","journal-title":"Annual Review of Pharmacology and Toxicology"},{"key":"10.1016\/j.pharmthera.2025.108944_bb0290","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/B978-0-12-374145-5.00151-0","article-title":"Leukotriene mediators","author":"Haeggstr\u00f6m","year":"2010","journal-title":"Handbook of Cell Signaling"},{"issue":"5","key":"10.1016\/j.pharmthera.2025.108944_bb0295","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.plefa.2005.07.006","article-title":"Dietary (n-3) fatty acids alter plasma fatty acids and leukotriene B synthesis by stimulated neutrophils from healthy geriatric beagles","volume":"73","author":"Hall","year":"2005","journal-title":"Prostaglandins, Leukotrienes, and Essential Fatty Acids"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2025.108944_bb0300","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.vetimm.2006.03.019","article-title":"Dietary antioxidants and behavioral enrichment enhance neutrophil phagocytosis in geriatric beagles","volume":"113","author":"Hall","year":"2006","journal-title":"Veterinary Immunology and Immunopathology"},{"issue":"9","key":"10.1016\/j.pharmthera.2025.108944_bb0305","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1016\/j.cell.2021.04.019","article-title":"The basic immunology of asthma","volume":"184","author":"Hammad","year":"2021","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108944_bb0310","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/imm.13308","article-title":"Montelukast alleviates inflammation in experimental autoimmune encephalomyelitis by altering Th17 differentiation in a mouse model","volume":"163","author":"Han","year":"2021","journal-title":"Immunology"},{"issue":"3","key":"10.1016\/j.pharmthera.2025.108944_bb0315","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1084\/jem.192.3.433","article-title":"Targeted disruption of the leukotriene B4 receptor in mice reveals its role in inflammation and platelet-activating factor-induced anaphylaxis","volume":"192","author":"Haribabu","year":"2000","journal-title":"The Journal of Experimental Medicine"},{"issue":"6","key":"10.1016\/j.pharmthera.2025.108944_bb0320","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1038\/s41385-022-00557-0","article-title":"Trained immunity in type 2 immune responses","volume":"15","author":"Hartung","year":"2022","journal-title":"Mucosal Immunology"},{"key":"10.1016\/j.pharmthera.2025.108944_bb0325","doi-asserted-by":"crossref","DOI":"10.3389\/fddsv.2024.1355044","article-title":"The (misleading) role of animal models in drug development","volume":"4","author":"Hartung","year":"2024","journal-title":"Frontiers in Drug Discovery"},{"key":"10.1016\/j.pharmthera.2025.108944_bb0330","doi-asserted-by":"crossref","DOI":"10.1177\/03946320251351083","article-title":"Blocking leukotriene receptors improve experimentally induced gastric ulcers in rats by inhibiting inflammation and apoptosis","volume":"39","author":"Hassan","year":"2025","journal-title":"International Journal of Immunopathology and Pharmacology"},{"issue":"4","key":"10.1016\/j.pharmthera.2025.108944_bb0335","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1136\/gut.33.4.513","article-title":"Colorectal leukotriene B4 synthesis in vitro in inflammatory bowel disease: inhibition by the selective 5-lipoxygenase inhibitor BWA4C","volume":"33","author":"Hawthorne","year":"1992","journal-title":"Gut"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2025.108944_bb0340","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/BF00583745","article-title":"A possible role for leukotrienes in the regulation of glomerular haemodynamics in the dog","volume":"412","author":"Heller","year":"1988","journal-title":"Pfl\u00fcgers Archiv"},{"issue":"9","key":"10.1016\/j.pharmthera.2025.108944_bb0345","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/intimm\/dxy087","article-title":"Prostanoids and leukotrienes in the pathophysiology of atopic dermatitis and psoriasis","volume":"31","author":"Honda","year":"2019","journal-title":"International Immunology"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108944_bb0350","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1432-1033.1990.tb19458.x","article-title":"Metabolism of cysteinyl leukotrienes in monkey and man","volume":"194","author":"Huber","year":"1990","journal-title":"European Journal of Biochemistry"},{"issue":"3","key":"10.1016\/j.pharmthera.2025.108944_bb0355","first-page":"370","article-title":"Endogenous arachidonic acid metabolism by calcium ionophore stimulated ferret lungs. Effect of age, hypoxia","volume":"66","author":"Ibe","year":"1992","journal-title":"Laboratory Investigation"},{"issue":"5\u20136","key":"10.1016\/j.pharmthera.2025.108944_bb0360","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0049-3848(03)00418-3","article-title":"Activation of nuclear receptors by prostaglandins","volume":"110","author":"Ide","year":"2003","journal-title":"Thrombosis Research"},{"issue":"5","key":"10.1016\/j.pharmthera.2025.108944_bb0365","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s12640-024-00720-4","article-title":"Impact of 5-lipoxygenase deficiency on dopamine-mediated behavioral responses","volume":"42","author":"Issy","year":"2024","journal-title":"Neurotoxicity Research"},{"key":"10.1016\/j.pharmthera.2025.108944_bb0370","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.pharmthera.2017.05.005","article-title":"Cytochrome P450-derived eicosanoids and heart function","volume":"179","author":"Jamieson","year":"2017","journal-title":"Pharmacology & Therapeutics"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108944_bb0375","first-page":"119","article-title":"Chronic models of airway inflammation, mucus hypersecretion and remodelling","volume":"2","author":"Jarman","year":"2005","journal-title":"Drug Discovery Today: Disease Models"},{"issue":"18","key":"10.1016\/j.pharmthera.2025.108944_bb0380","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1038\/s41388-024-03016-1","article-title":"The role of human 5-lipoxygenase (5-LO) in carcinogenesis - a question of canonical and non-canonical functions","volume":"43","author":"Kahnt","year":"2024","journal-title":"Oncogene"},{"issue":"16","key":"10.1016\/j.pharmthera.2025.108944_bb0385","doi-asserted-by":"crossref","first-page":"10967","DOI":"10.1074\/jbc.C113.453704","article-title":"Identification of GPR99 protein as a potential third cysteinyl leukotriene receptor with a preference for leukotriene E4 ligand","volume":"288","author":"Kanaoka","year":"2013","journal-title":"The Journal of Biological Chemistry"},{"issue":"25","key":"10.1016\/j.pharmthera.2025.108944_bb0390","doi-asserted-by":"crossref","first-page":"22608","DOI":"10.1074\/jbc.M103562200","article-title":"Attenuated zymosan-induced peritoneal vascular permeability and IgE-dependent passive cutaneous anaphylaxis in mice lacking leukotriene C4 synthase","volume":"276","author":"Kanaoka","year":"2001","journal-title":"The Journal of Biological Chemistry"},{"issue":"9","key":"10.1016\/j.pharmthera.2025.108944_bb0395","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1002\/jps.2600810907","article-title":"Rate-limiting steps in oral absorption of a leucotriene D4 antagonist in the beagle dog","volume":"81","author":"Kararli","year":"1992","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"9","key":"10.1016\/j.pharmthera.2025.108944_bb0400","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1038\/s41556-020-0564-2","article-title":"Lipid peroxidation regulates long-range wound detection through 5-lipoxygenase in zebrafish","volume":"22","author":"Katikaneni","year":"2020","journal-title":"Nature Cell Biology"},{"issue":"4","key":"10.1016\/j.pharmthera.2025.108944_bb0405","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.bbalip.2014.07.008","article-title":"Prostaglandin E2-induced inflammation: Relevance of prostaglandin E receptors","volume":"1851","author":"Kawahara","year":"2015","journal-title":"Biochimica et Biophysica Acta"},{"issue":"3","key":"10.1016\/j.pharmthera.2025.108944_bb0410","doi-asserted-by":"crossref","first-page":"376","DOI":"10.12996\/gmj.2025.4388","article-title":"Cyclooxygenases and lipoxygenases in cancer drug resistance","volume":"36","author":"Kazan","year":"2025","journal-title":"Gazi Medical Journal"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108944_bb0415","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1124\/dmd.104.001677","article-title":"Formation and protein binding of the acyl glucuronide of a leukotriene B4 antagonist (SB-209247): Relation to species differences in hepatotoxicity","volume":"33","author":"Kenny","year":"2005","journal-title":"Drug Metabolism and Disposition"},{"issue":"3","key":"10.1016\/j.pharmthera.2025.108944_bb0420","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.bbrc.2010.03.049","article-title":"The leukotriene B4 receptor, BLT1, is required for the induction of experimental autoimmune encephalomyelitis","volume":"394","author":"Kihara","year":"2010","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"7","key":"10.1016\/j.pharmthera.2025.108944_bb0425","doi-asserted-by":"crossref","first-page":"4440","DOI":"10.4049\/jimmunol.176.7.4440","article-title":"Cysteinyl leukotrienes regulate Th2 cell-dependent pulmonary inflammation","volume":"176","author":"Kim","year":"2006","journal-title":"Journal of Immunology"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108944_bb0430","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1152\/physrev.00041.2018","article-title":"Free fatty acid receptors in health and disease","volume":"100","author":"Kimura","year":"2020","journal-title":"Physiological Reviews"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108944_bb0435","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0022-3565(24)36889-2","article-title":"Evaluation of the antiinflammatory activity of a dual cyclooxygenase-2 selective\/5-lipoxygenase inhibitor, RWJ 63556, in a canine model of inflammation","volume":"282","author":"Kirchner","year":"1997","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108944_bb0440","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens13010035","article-title":"Comparative pathology of animal models for influenza A virus infection","volume":"13","author":"Kirk","year":"2023","journal-title":"Pathogens"},{"issue":"6","key":"10.1016\/j.pharmthera.2025.108944_bb0445","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1038\/s41423-020-00559-7","article-title":"Expression of leukotriene B4 receptor 1 defines functionally distinct DCs that control allergic skin inflammation","volume":"18","author":"Koga","year":"2021","journal-title":"Cellular & Molecular Immunology"},{"issue":"5 Pt 1","key":"10.1016\/j.pharmthera.2025.108944_bb0450","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/S0016-5085(87)91079-1","article-title":"Effects of leukotrienes on gastric acid and alkaline secretions","volume":"92","author":"Konturek","year":"1987","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pharmthera.2025.108944_bb0455","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2024.1451902","article-title":"Evaluation of the covariation between leukotriene B4, prostaglandin E2, and hematologic inflammatory parameters in a canine pentylenetetrazole-induced seizure model","volume":"18","author":"Koo","year":"2024","journal-title":"Frontiers in Neuroscience"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108944_bb0460","doi-asserted-by":"crossref","first-page":"5936","DOI":"10.1038\/s41598-019-42410-8","article-title":"Mediatory roles of leukotriene B4 receptors in LPS-induced endotoxic shock","volume":"9","author":"Kwon","year":"2019","journal-title":"Scientific Reports"},{"issue":"7454","key":"10.1016\/j.pharmthera.2025.108944_bb0465","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nature12175","article-title":"Neutrophil swarms require LTB4 and integrins at sites of cell death in vivo","volume":"498","author":"Lammermann","year":"2013","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108944_bb0470","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.chom.2017.11.009","article-title":"Leukotriene B4-nediated neutrophil recruitment causes pulmonary capillaritis during lethal fungal sepsis","volume":"23","author":"Lee","year":"2018","journal-title":"Cell Host & Microbe"},{"issue":"3","key":"10.1016\/j.pharmthera.2025.108944_bb0475","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/BF02714946","article-title":"Electromechanical effects of leukotriene D4 on ferret tracheal muscle and its muscarinic responsiveness","volume":"167","author":"Lee","year":"1989","journal-title":"Lung"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108944_bb0480","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/cid\/ciad187","article-title":"Evaluation of Acebilustat, a selective inhibitor of leukotriene B4 biosynthesis, for treatment of outpatients with mild-moderate coronavirus disease 2019: A randomized, double-blind, placebo-controlled phase 2 trial","volume":"77","author":"Levitt","year":"2023","journal-title":"Clinical Infectious Diseases"},{"issue":"19","key":"10.1016\/j.pharmthera.2025.108944_bb0485","doi-asserted-by":"crossref","first-page":"6212","DOI":"10.1073\/pnas.81.19.6212","article-title":"Leukotrienes in the rat central nervous system","volume":"81","author":"Lindgren","year":"1984","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"8","key":"10.1016\/j.pharmthera.2025.108944_bb0490","doi-asserted-by":"crossref","first-page":"11752","DOI":"10.18632\/aging.202869","article-title":"5-lipoxygenase inhibition reduces inflammation and neuronal apoptosis via AKT signaling after subarachnoid hemorrhage in rats","volume":"13","author":"Liu","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.pharmthera.2025.108944_bb0495","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105922","article-title":"Deficiency of astrocyte CysLT(1)R ameliorates depression-like behaviors in mice by modulating glutamate synaptic transmission","volume":"175","author":"Liu","year":"2022","journal-title":"Neurobiology of Disease"},{"issue":"169","key":"10.1016\/j.pharmthera.2025.108944_bb0500","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0079-2023","article-title":"Neuropsychiatric events associated with montelukast in patients with asthma: a systematic review","volume":"32","author":"Lo","year":"2023","journal-title":"European Respiratory Review"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108944_bb0505","doi-asserted-by":"crossref","DOI":"10.1111\/cts.13724","article-title":"LTA4H inhibitor LYS006: Clinical PK\/PD and safety in a randomized phase I clinical trial","volume":"17","author":"Loesche","year":"2024","journal-title":"Clinical and Translational Science"},{"issue":"10","key":"10.1016\/j.pharmthera.2025.108944_bb0510","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.105247","article-title":"Structural diversity of leukotriene G-protein coupled receptors","volume":"299","author":"Luginina","year":"2023","journal-title":"The Journal of Biological Chemistry"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108944_bb0515","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111974","article-title":"Oxoeicosanoid signaling mediates early antimicrobial defense in zebrafish","volume":"42","author":"Ma","year":"2023","journal-title":"Cell Reports"},{"issue":"23","key":"10.1016\/j.pharmthera.2025.108944_bb0520","doi-asserted-by":"crossref","first-page":"20820","DOI":"10.1074\/jbc.M203163200","article-title":"Targeted gene disruption reveals the role of cysteinyl leukotriene 1 receptor in the enhanced vascular permeability of mice undergoing acute inflammatory responses","volume":"277","author":"Maekawa","year":"2002","journal-title":"The Journal of Biological Chemistry"},{"issue":"3","key":"10.1016\/j.pharmthera.2025.108944_bb0525","doi-asserted-by":"crossref","DOI":"10.1002\/prca.201700087","article-title":"Establishment of a CRISPR\/Cas9-mediated Cysltr1 knockout mouse model and iTRAQ-based proteomic analysis","volume":"12","author":"Mao","year":"2018","journal-title":"Proteomics. Clinical Applications"},{"issue":"5","key":"10.1016\/j.pharmthera.2025.108944_bb0530","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.4049\/jimmunol.1001031","article-title":"Nonredundant roles for leukotriene B4 receptors BLT1 and BLT2 in inflammatory arthritis","volume":"185","author":"Mathis","year":"2010","journal-title":"Journal of Immunology"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108944_bb0535","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0005-2760(88)90115-4","article-title":"Leukotriene A4: metabolism in different rat tissues","volume":"961","author":"Medina","year":"1988","journal-title":"Biochimica et Biophysica Acta"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108944_bb0540","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1161\/01.RES.0000028008.99774.7F","article-title":"Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis susceptibility in mice","volume":"91","author":"Mehrabian","year":"2002","journal-title":"Circulation Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108944_bb0545","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s40478-020-00989-4","article-title":"Microglia depletion diminishes key elements of the leukotriene pathway in the brain of Alzheimer\u2019s disease mice","volume":"8","author":"Michael","year":"2020","journal-title":"Acta Neuropathologica Communications"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108944_bb0550","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0014-5793(87)80769-X","article-title":"Regional distribution of leukotriene and mono-hydroxyeicosatetraenoic acid production in the rat brain. Highest leukotriene C4 formation in the hypothalamus","volume":"216","author":"Miyamoto","year":"1987","journal-title":"FEBS Letters"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108944_bb0555","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1165\/rcmb.2012-0525OC","article-title":"Pivotal role of the 5-lipoxygenase pathway in lung injury after experimental sepsis","volume":"50","author":"Monteiro","year":"2014","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"issue":"4","key":"10.1016\/j.pharmthera.2025.108944_bb0560","doi-asserted-by":"crossref","first-page":"F732","DOI":"10.1152\/ajprenal.00262.2018","article-title":"Inhibition of 5-lipoxygenase decreases renal fibrosis and progression of chronic kidney disease","volume":"316","author":"Montford","year":"2019","journal-title":"American Journal of Physiology. Renal Physiology"},{"issue":"12","key":"10.1016\/j.pharmthera.2025.108944_bb0565","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1111\/j.1365-2222.2010.03630.x","article-title":"Leukotriene modifiers for asthma treatment","volume":"40","author":"Montuschi","year":"2010","journal-title":"Clinical and Experimental Allergy"},{"key":"10.1016\/j.pharmthera.2025.108944_bb0570","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2023.1140708","article-title":"Leukotriene signaling as molecular correlate for cognitive heterogeneity in aging: an exploratory study","volume":"15","author":"Mrowetz","year":"2023","journal-title":"Frontiers in Aging Neuroscience"},{"issue":"17","key":"10.1016\/j.pharmthera.2025.108944_bb0575","doi-asserted-by":"crossref","first-page":"7769","DOI":"10.1021\/acs.jmedchem.9b00555","article-title":"Discovery of the oral leukotriene C4 synthase inhibitor (1S,2S)-2-(5-[(5-Chloro-2,4-difluorophenyl)(2-fluoro-2-methylpropyl)amino]-3-methoxypyrazin-2-ylcarbonyl)cyclopropanecarboxylic acid (AZD9898) as a new treatment for asthma","volume":"62","author":"Munck Af Rosenschold","year":"2019","journal-title":"Journal of Medicinal Chemistry"},{"issue":"6","key":"10.1016\/j.pharmthera.2025.108944_bb0580","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1152\/jappl.1989.66.6.2533","article-title":"Electromechanical coupling of ferret airway smooth muscle in response to leukotriene C4","volume":"66","author":"Murlas","year":"1989","journal-title":"Journal of Applied Physiology (Bethesda, MD: 1985)"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108944_bb0585","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0006-2952(94)90232-1","article-title":"Modulation of pulmonary leukotriene formation and perfusion pressure by bestatin, an inhibitor of leukotriene A4 hydrolase","volume":"48","author":"Muskardin","year":"1994","journal-title":"Biochemical Pharmacology"},{"issue":"4\u20135","key":"10.1016\/j.pharmthera.2025.108944_bb0590","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1242\/dmm.000323","article-title":"Mouse models of allergic asthma: acute and chronic allergen challenge","volume":"1","author":"Nials","year":"2008","journal-title":"Disease Models & Mechanisms"},{"issue":"5","key":"10.1016\/j.pharmthera.2025.108944_bb0595","doi-asserted-by":"crossref","first-page":"L638","DOI":"10.1152\/ajplung.00422.2024","article-title":"Allergic airway inflammation amplifies mast cell responses in isolated guinea pig intralobular bronchi","volume":"328","author":"Nie","year":"2025","journal-title":"American Journal of Physiology. Lung Cellular and Molecular Physiology"},{"issue":"8","key":"10.1016\/j.pharmthera.2025.108944_bb0600","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1248\/bpb.34.1163","article-title":"Leukotrienes in nociceptive pathway and neuropathic\/inflammatory pain","volume":"34","author":"Noguchi","year":"2011","journal-title":"Biological & Pharmaceutical Bulletin"},{"issue":"3\u20134","key":"10.1016\/j.pharmthera.2025.108944_bb0605","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/BF01967302","article-title":"Sulphur dioxide-induced airway hyperreactivity and pulmonary inflammation in dogs","volume":"26","author":"Norris","year":"1989","journal-title":"Agents and Actions"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108944_bb0610","doi-asserted-by":"crossref","first-page":"13591","DOI":"10.1038\/s41598-017-13490-1","article-title":"Feasibility and physiological relevance of designing highly potent aminopeptidase-sparing leukotriene A4 hydrolase inhibitors","volume":"7","author":"Numao","year":"2017","journal-title":"Scientific Reports"},{"issue":"6","key":"10.1016\/j.pharmthera.2025.108944_bb0615","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1165\/rcmb.2013-0009OC","article-title":"Cys-leukotrienes promote fibrosis in a mouse model of eosinophil-mediated respiratory inflammation","volume":"49","author":"Ochkur","year":"2013","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"issue":"10","key":"10.1016\/j.pharmthera.2025.108944_bb0620","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2025.110629","article-title":"Recent updates in mammalian oxylipin biochemistry","volume":"301","author":"O\u2019Donnell","year":"2025","journal-title":"The Journal of Biological Chemistry"},{"issue":"4","key":"10.1016\/j.pharmthera.2025.108944_bb0625","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1053\/gast.2000.18141","article-title":"Leukotrienes induce cell-survival signaling in intestinal epithelial cells","volume":"119","author":"\u00d6hd","year":"2000","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.pharmthera.2025.108944_bb0630","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/glia.20948","article-title":"Leukotriene synthases and the receptors induced by peripheral nerve injury in the spinal cord contribute to the generation of neuropathic pain","volume":"58","author":"Okubo","year":"2010","journal-title":"Glia"},{"issue":"11","key":"10.1016\/j.pharmthera.2025.108944_bb0635","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.bbagen.2011.02.005","article-title":"Leukotrienes and airway inflammation","volume":"1810","author":"Okunishi","year":"2011","journal-title":"Biochimica et Biophysica Acta"},{"issue":"4","key":"10.1016\/j.pharmthera.2025.108944_bb0640","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1084\/jem.20072329","article-title":"12(S)-Hydroxyheptadeca-5Z, 8E, 10E-trienoic acid is a natural ligand for leukotriene B4 receptor 2","volume":"205","author":"Okuno","year":"2008","journal-title":"The Journal of Experimental Medicine"},{"issue":"3","key":"10.1016\/j.pharmthera.2025.108944_bb0645","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0021-9258(18)52303-6","article-title":"Leukotriene A4 hydrolase. Inhibition by bestatin and intrinsic aminopeptidase activity establish its functional resemblance to metallohydrolase enzymes","volume":"266","author":"Orning","year":"1991","journal-title":"The Journal of Biological Chemistry"},{"issue":"21","key":"10.1016\/j.pharmthera.2025.108944_bb0650","doi-asserted-by":"crossref","first-page":"34773","DOI":"10.18632\/oncotarget.16718","article-title":"Cysteinyl leukotriene receptor 1 facilitates tumorigenesis in a mouse model of colitis-associated colon cancer","volume":"8","author":"Osman","year":"2017","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.pharmthera.2025.108944_bb0655","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.cell.2024.01.042","article-title":"Past, present, and future of CRISPR genome editing technologies","volume":"187","author":"Pacesa","year":"2024","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108944_bb0660","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s42826-025-00253-7","article-title":"Physiological and immunological aspects of asthma: the guinea pig (Cavia porcellus) as a model of allergic asthma","volume":"41","author":"Pacheco-Alba","year":"2025","journal-title":"Laboratory Animal Research"},{"issue":"4","key":"10.1016\/j.pharmthera.2025.108944_bb0665","first-page":"462","article-title":"Effects of combined receptor antagonists of leukotriene D4 (LTD4) and platelet-activating factor (PAF) on rhesus airway responses to LTD4, PAF and antigen","volume":"88","author":"Patterson","year":"1989","journal-title":"International Archives of Allergy and Applied Immunology"},{"key":"10.1016\/j.pharmthera.2025.108944_bb0670","doi-asserted-by":"crossref","DOI":"10.1016\/j.archoralbio.2020.104670","article-title":"Effects of 5-lipoxygenase gene disruption on inflammation, osteoclastogenesis and bone resorption in polymicrobial apical periodontitis","volume":"112","author":"Paula-Silva","year":"2020","journal-title":"Archives of Oral Biology"},{"issue":"23","key":"10.1016\/j.pharmthera.2025.108944_bb0675","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1016\/S0960-894X(02)00760-6","article-title":"Pyrrolidine and piperidine analogues of SC-57461A as potent, orally active inhibitors of leukotriene A4 hydrolase","volume":"12","author":"Penning","year":"2002","journal-title":"Bioorganic & Medicinal Chemistry Letters"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108944_bb0680","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1164\/ajrccm.165.2.2104050","article-title":"Protection from pulmonary fibrosis in leukotriene-deficient mice","volume":"165","author":"Peters-Golden","year":"2002","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"18","key":"10.1016\/j.pharmthera.2025.108944_bb0685","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1056\/NEJMra071371","article-title":"Leukotrienes","volume":"357","author":"Peters-Golden","year":"2007","journal-title":"The New England Journal of Medicine"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108944_bb0690","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/cvr\/cvq016","article-title":"The 5-lipoxygenase\/leukotriene pathway in preclinical models of cardiovascular disease","volume":"86","author":"Poeckel","year":"2010","journal-title":"Cardiovascular Research"},{"issue":"16","key":"10.1016\/j.pharmthera.2025.108944_bb0695","doi-asserted-by":"crossref","first-page":"9616","DOI":"10.1016\/S0021-9258(17)44539-X","article-title":"Leukotriene C4 binding to rat lung membranes","volume":"258","author":"Pong","year":"1983","journal-title":"The Journal of Biological Chemistry"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108944_bb0700","doi-asserted-by":"crossref","first-page":"17658","DOI":"10.1038\/s41598-017-17993-9","article-title":"Leukotriene B4 is essential for lung host defence and alpha-defensin-1 production during Achromobacter xylosoxidans infection","volume":"7","author":"Prado","year":"2017","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2025.108944_bb0705","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ijcard.2022.07.016","article-title":"Safety and efficacy of the 5-lipoxygenase-activating protein inhibitor AZD5718 in patients with recent myocardial infarction: The phase 2a FLAVOUR study","volume":"365","author":"Prescott","year":"2022","journal-title":"International Journal of Cardiology"},{"issue":"6","key":"10.1016\/j.pharmthera.2025.108944_bb0710","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1093\/toxres\/tfaa081","article-title":"Justification for species selection for pharmaceutical toxicity studies","volume":"9","author":"Prior","year":"2020","journal-title":"Toxicol Res (Camb)"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108944_bb0715","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.amjms.2023.04.012","article-title":"Efficacy and safety of intravenous leukotriene receptor antagonists in acute asthma","volume":"366","author":"Qahtani","year":"2023","journal-title":"The American Journal of the Medical Sciences"},{"issue":"21","key":"10.1016\/j.pharmthera.2025.108944_bb0720","doi-asserted-by":"crossref","first-page":"8161","DOI":"10.1073\/pnas.0602414103","article-title":"Expression of 5-lipoxygenase and leukotriene A4 hydrolase in human atherosclerotic lesions correlates with symptoms of plaque instability","volume":"103","author":"Qiu","year":"2006","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"4","key":"10.1016\/j.pharmthera.2025.108944_bb0725","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.bbalip.2014.08.012","article-title":"5-lipoxygenase, a key enzyme for leukotriene biosynthesis in health and disease","volume":"1851","author":"R\u00e5dmark","year":"2015","journal-title":"Biochimica et Biophysica Acta"},{"issue":"9","key":"10.1016\/j.pharmthera.2025.108944_bb0730","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1111\/ijd.17172","article-title":"Leukotriene receptor antagonists as adjuvant therapy of antihistamines in chronic urticaria: a systematic review and meta-analysis","volume":"63","author":"Ribeiro Goncalves","year":"2024","journal-title":"International Journal of Dermatology"},{"issue":"5","key":"10.1016\/j.pharmthera.2025.108944_bb0735","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1161\/ATVBAHA.110.207449","article-title":"Prostaglandins and inflammation","volume":"31","author":"Ricciotti","year":"2011","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108944_bb0740","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0022-3565(25)22650-7","article-title":"Role of cyclooxygenase products of arachidonic acid metabolism in Ascaris antigen-induced bronchoconstriction in sensitized dogs","volume":"245","author":"Richards","year":"1988","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"12","key":"10.1016\/j.pharmthera.2025.108944_bb0745","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1080\/17460441.2021.1948998","article-title":"Drug discovery strategies for novel leukotriene A4 hydrolase inhibitors","volume":"16","author":"R\u00f6hn","year":"2021","journal-title":"Expert Opinion on Drug Discovery"},{"issue":"9","key":"10.1016\/j.pharmthera.2025.108944_bb0750","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/ncb437","article-title":"The mouse ascending: perspectives for human-disease models","volume":"9","author":"Rosenthal","year":"2007","journal-title":"Nature Cell Biology"},{"issue":"11","key":"10.1016\/j.pharmthera.2025.108944_bb0755","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/exd.12239","article-title":"Leukotrienes orchestrating allergic skin inflammation","volume":"22","author":"Sadik","year":"2013","journal-title":"Experimental Dermatology"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108944_bb0760","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1254\/jphs.FP0061169","article-title":"Action of cyclooxygenase inhibitors and a leukotriene biosynthesis inhibitor on cisplatin-induced acute and delayed emesis in the ferret","volume":"103","author":"Sam","year":"2007","journal-title":"Journal of Pharmacological Sciences"},{"key":"10.1016\/j.pharmthera.2025.108944_bb0765","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1126\/science.2820055","article-title":"Leukotrienes and lipoxins: Structures, biosynthesis, and biological effects","volume":"237","author":"Samuelsson","year":"1987","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.pharmthera.2025.108944_bb0770","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/intimm\/dxz044","article-title":"The leukotriene receptors as therapeutic targets of inflammatory diseases","volume":"31","author":"Sasaki","year":"2019","journal-title":"International Immunology"},{"issue":"5","key":"10.1016\/j.pharmthera.2025.108944_bb0775","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23052548","article-title":"Recent advances in the production of genome-edited rats","volume":"23","author":"Sato","year":"2022","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108944_bb0780","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00018-004-4366-7","article-title":"Microsomal glutathione S-transferases: selective up-regulation of leukotriene C4 synthase during lipopolysaccharide-induced pyresis","volume":"62","author":"Schr\u00f6der","year":"2005","journal-title":"Cellular and Molecular Life Sciences"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108944_bb0785","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.bbrc.2003.10.115","article-title":"Molecular and catalytic properties of three rat leukotriene C4 synthase homologs","volume":"312","author":"Schr\u00f6der","year":"2003","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"3","key":"10.1016\/j.pharmthera.2025.108944_bb0790","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1152\/japplphysiol.00162.2011","article-title":"Bronchoconstriction in nonhuman primates: a species comparison","volume":"111","author":"Seehase","year":"2011","journal-title":"Journal of Applied Physiology (Bethesda, MD: 1985)"},{"issue":"3","key":"10.1016\/j.pharmthera.2025.108944_bb0795","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1189\/jlb.71.3.410","article-title":"Thioglycollate peritonitis in mice lacking C5, 5-lipoxygenase, or p47(phox): complement, leukotrienes, and reactive oxidants in acute inflammation","volume":"71","author":"Segal","year":"2002","journal-title":"Journal of Leukocyte Biology"},{"issue":"3","key":"10.1016\/j.pharmthera.2025.108944_bb0800","doi-asserted-by":"crossref","first-page":"221","DOI":"10.4049\/jimmunol.2200599","article-title":"Leukotrienes in innate immunity: Still underappreciated after all these years?","volume":"210","author":"Serezani","year":"2023","journal-title":"Journal of Immunology"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108944_bb0805","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a016311","article-title":"Lipid mediators in the resolution of inflammation","volume":"7","author":"Serhan","year":"2015","journal-title":"Cold Spring Harbor Perspectives in Biology"},{"issue":"10","key":"10.1016\/j.pharmthera.2025.108944_bb0810","doi-asserted-by":"crossref","first-page":"6254","DOI":"10.4049\/jimmunol.176.10.6254","article-title":"Targeted disruption of leukotriene B4 receptors BLT1 and BLT2: a critical role for BLT1 in collagen-induced arthritis in mice","volume":"176","author":"Shao","year":"2006","journal-title":"Journal of Immunology"},{"issue":"6","key":"10.1016\/j.pharmthera.2025.108944_bb0815","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1007\/s10787-024-01557-1","article-title":"Leukotriene signaling in neurodegeneration: Implications for treatment strategies","volume":"32","author":"Sharma","year":"2024","journal-title":"Inflammopharmacology"},{"issue":"3","key":"10.1016\/j.pharmthera.2025.108944_bb0820","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0016-5085(84)80015-3","article-title":"Enhanced synthesis of leukotriene B4 by colonic mucosa in inflammatory bowel disease","volume":"86","author":"Sharon","year":"1984","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.pharmthera.2025.108944_bb0825","doi-asserted-by":"crossref","first-page":"L749","DOI":"10.1152\/ajplung.00116.2010","article-title":"Role of LTB4 in the pathogenesis of elastase-induced murine pulmonary emphysema","volume":"299","author":"Shim","year":"2010","journal-title":"American Journal of Physiology. Lung Cellular and Molecular Physiology"},{"issue":"3","key":"10.1016\/j.pharmthera.2025.108944_bb0830","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.intimp.2013.09.017","article-title":"Effects of montelukast on subepithelial\/peribronchial fibrosis in a murine model of ovalbumin induced chronic asthma","volume":"17","author":"Shin","year":"2013","journal-title":"International Immunopharmacology"},{"issue":"7","key":"10.1016\/j.pharmthera.2025.108944_bb0835","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1007\/s10787-025-01776-0","article-title":"5-lipoxygenase is critically involved in joint inflammation and damage in experimental osteoarthritis","volume":"33","author":"Silva","year":"2025","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.pharmthera.2025.108944_bb0840","article-title":"A current review on animal models of anti-asthmatic drugs screening","volume":"16","author":"Singh","year":"2025","journal-title":"Frontiers in Pharmacology"},{"issue":"5847","key":"10.1016\/j.pharmthera.2025.108944_bb0845","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/295327a0","article-title":"Leukotriene C4 affects pulmonary and cardiovascular dynamics in monkey","volume":"295","author":"Smedegard","year":"1982","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2025.108944_bb0850","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev.pa.29.040189.001011","article-title":"Leukotriene receptor antagonists as potential therapeutic agents","volume":"29","author":"Snyder","year":"1989","journal-title":"Annual Review of Pharmacology and Toxicology"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108944_bb0855","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0090-6980(86)90124-3","article-title":"Pharmacology of peptide leukotrienes on ferret isolated airway smooth muscle","volume":"32","author":"Snyder","year":"1986","journal-title":"Prostaglandins"},{"key":"10.1016\/j.pharmthera.2025.108944_bb0860","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2020.104757","article-title":"Advances in selecting appropriate non-rodent species for regulatory toxicology research: Policy, ethical, and experimental considerations","volume":"116","author":"Son","year":"2020","journal-title":"Regulatory Toxicology and Pharmacology"},{"key":"10.1016\/j.pharmthera.2025.108944_bb0865","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176755","article-title":"Neuromodulatory effects of leukotriene receptor antagonists: A comprehensive review","volume":"978","author":"Sood","year":"2024","journal-title":"European Journal of Pharmacology"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108944_bb0870","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s42826-024-00195-6","article-title":"A review of animal models utilized in preclinical studies of approved gene therapy products: trends and insights","volume":"40","author":"Soufizadeh","year":"2024","journal-title":"Laboratory Animal Research"},{"issue":"3","key":"10.1016\/j.pharmthera.2025.108944_bb0875","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1073\/pnas.242716099","article-title":"Expanding expression of the 5-lipoxygenase pathway within the arterial wall during human atherogenesis","volume":"100","author":"Spanbroek","year":"2003","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"4","key":"10.1016\/j.pharmthera.2025.108944_bb0880","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/0090-6980(90)90124-E","article-title":"Production of leukotrienes in phorbol ester-induced acute lung injury","volume":"39","author":"Sprague","year":"1990","journal-title":"Prostaglandins"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108944_bb0885","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/ki.1991.12","article-title":"Enhanced renal leukotriene production in murine lupus: role of lipoxygenase metabolites","volume":"39","author":"Spurney","year":"1991","journal-title":"Kidney International"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108944_bb0890","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0008-6363(00)00238-8","article-title":"Cysteinyl leukotrienes are involved in angiotensin II-induced contraction of aorta from spontaneously hypertensive rats","volume":"49","author":"Stanke-Labesque","year":"2001","journal-title":"Cardiovascular Research"},{"issue":"6","key":"10.1016\/j.pharmthera.2025.108944_bb0895","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/ibd.20403","article-title":"Urinary leukotriene E4 excretion: a biomarker of inflammatory bowel disease activity","volume":"14","author":"Stanke-Labesque","year":"2008","journal-title":"Inflammatory Bowel Diseases"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108944_bb0900","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1152\/jappl.1987.62.2.732","article-title":"Increased leukotriene C4 in ethchlorvynol-induced acute lung injury in dogs","volume":"62","author":"Stephenson","year":"1987","journal-title":"Journal of Applied Physiology (Bethesda, MD: 1985)"},{"key":"10.1016\/j.pharmthera.2025.108944_bb0905","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/1471-2202-13-146","article-title":"Disruption of the alox5ap gene ameliorates focal ischemic stroke: possible consequence of impaired leukotriene biosynthesis","volume":"13","author":"Str\u00f6m","year":"2012","journal-title":"BMC Neuroscience"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108944_bb0910","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1161\/01.ATV.0000110503.16605.15","article-title":"Role of leukotriene B4 receptors in the development of atherosclerosis: potential mechanisms","volume":"24","author":"Subbarao","year":"2004","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"issue":"9","key":"10.1016\/j.pharmthera.2025.108944_bb0915","doi-asserted-by":"crossref","first-page":"4361","DOI":"10.4049\/jimmunol.1302959","article-title":"Interplay between CXCR2 and BLT1 facilitates neutrophil infiltration and resultant keratinocyte activation in a murine model of imiquimod-induced psoriasis","volume":"192","author":"Sumida","year":"2014","journal-title":"The Journal of Immunology"},{"issue":"9","key":"10.1016\/j.pharmthera.2025.108944_bb0920","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1093\/carcin\/bgl039","article-title":"Involvement of the 5-lipoxygenase\/leukotriene A4 hydrolase pathway in 7,12-dimethylbenz[a]anthracene (DMBA)-induced oral carcinogenesis in hamster cheek pouch, and inhibition of carcinogenesis by its inhibitors","volume":"27","author":"Sun","year":"2006","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108944_bb0925","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s12929-020-00673-8","article-title":"Rat models of human diseases and related phenotypes: a systematic inventory of the causative genes","volume":"27","author":"Szpirer","year":"2020","journal-title":"Journal of Biomedical Science"},{"issue":"3","key":"10.1016\/j.pharmthera.2025.108944_bb0930","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1084\/jem.192.3.439","article-title":"BLTR mediates leukotriene B4-induced chemotaxis and adhesion and plays a dominant role in eosinophil accumulation in a murine model of peritonitis","volume":"192","author":"Tager","year":"2000","journal-title":"The Journal of Experimental Medicine"},{"issue":"12","key":"10.1016\/j.pharmthera.2025.108944_bb0935","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1194\/jlr.M054072","article-title":"Lipoxygenase-catalyzed transformation of epoxy fatty acids to hydroxy-endoperoxides: a potential P450 and lipoxygenase interaction","volume":"55","author":"Teder","year":"2014","journal-title":"Journal of Lipid Research"},{"key":"10.1016\/j.pharmthera.2025.108944_bb0940","doi-asserted-by":"crossref","DOI":"10.1016\/j.prostaglandins.2023.106760","article-title":"Cross-talk between bioactive lipid mediators and the unfolded protein response in ischemic stroke","volume":"168","author":"Teder","year":"2023","journal-title":"Prostaglandins & Other Lipid Mediators"},{"issue":"8","key":"10.1016\/j.pharmthera.2025.108944_bb0945","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24087539","article-title":"Modulation of the 5-lipoxygenase pathway by chalcogen-containing inhibitors of leukotriene A4 hydrolase","volume":"24","author":"Teder","year":"2023","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2025.108944_bb0950","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2019.108126","article-title":"Distinct characteristics of the substrate binding between highly homologous catalase-related allene oxide synthase and hydroperoxide lyase","volume":"676","author":"Teder","year":"2019","journal-title":"Archives of Biochemistry and Biophysics"},{"issue":"4","key":"10.1016\/j.pharmthera.2025.108944_bb0955","doi-asserted-by":"crossref","first-page":"4721","DOI":"10.1021\/acs.jmedchem.4c02897","article-title":"Discovery of GJG057, a potent and highly selective inhibitor of leukotriene C4 synthase","volume":"68","author":"Thoma","year":"2025","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2025.108944_bb0960","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.3389\/fphar.2020.01289","article-title":"Leukotrienes in tumor-associated inflammation","volume":"11","author":"Tian","year":"2020","journal-title":"Frontiers in Pharmacology"},{"issue":"200","key":"10.1016\/j.pharmthera.2025.108944_bb0965","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3006674","article-title":"Blocking macrophage leukotriene B4 prevents endothelial injury and reverses pulmonary hypertension","volume":"5","author":"Tian","year":"2013","journal-title":"Science Translational Medicine"},{"issue":"4","key":"10.1016\/j.pharmthera.2025.108944_bb0970","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S1074-7613(04)00084-6","article-title":"The use of zebrafish to understand immunity","volume":"20","author":"Trede","year":"2004","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108944_bb0975","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1152\/jappl.1990.68.1.253","article-title":"Does leukotriene C4 mediate hypoxic vasoconstriction in isolated ferret lungs?","volume":"68","author":"Tseng","year":"1990","journal-title":"Journal of Applied Physiology (1985)"},{"issue":"3","key":"10.1016\/j.pharmthera.2025.108944_bb0980","first-page":"PL51","article-title":"Involvement of leukotriene B4 in arthritis models","volume":"64","author":"Tsuji","year":"1999","journal-title":"Life Sciences"},{"issue":"3","key":"10.1016\/j.pharmthera.2025.108944_bb0985","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0014-2999(94)00485-4","article-title":"BAY u9773, a novel antagonist of cysteinyl-leukotrienes with activity against two receptor subtypes","volume":"264","author":"Tudhope","year":"1994","journal-title":"European Journal of Pharmacology"},{"issue":"4","key":"10.1016\/j.pharmthera.2025.108944_bb0990","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1365-3164.1994.tb00028.x","article-title":"Evaluation of effects of dietary n-6 to n-3 fatty acid ratios on leukotriene B synthesis in dog skin and neutrophils","volume":"5","author":"Vaughn","year":"1994","journal-title":"Veterinary Dermatology"},{"issue":"13","key":"10.1016\/j.pharmthera.2025.108944_bb0995","article-title":"The CysLT(2)R receptor mediates leukotriene C4-driven acute and chronic itch","volume":"118","author":"Voisin","year":"2021","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"8","key":"10.1016\/j.pharmthera.2025.108944_bb1000","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1111\/bph.14178","article-title":"Eicosanoids in the gastrointestinal tract","volume":"176","author":"Wallace","year":"2019","journal-title":"British Journal of Pharmacology"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108944_bb1005","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0016-5085(89)90760-9","article-title":"Inhibition of leukotriene synthesis markedly accelerates healing in a rat model of inflammatory bowel disease","volume":"96","author":"Wallace","year":"1989","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108944_bb1010","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41392-020-00443-w","article-title":"Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets","volume":"6","author":"Wang","year":"2021","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"9","key":"10.1016\/j.pharmthera.2025.108944_bb1015","doi-asserted-by":"crossref","first-page":"805","DOI":"10.2165\/00002018-200730090-00006","article-title":"Clinical pattern of zileuton-associated liver injury: results of a 12-month study in patients with chronic asthma","volume":"30","author":"Watkins","year":"2007","journal-title":"Drug Safety"},{"issue":"5799","key":"10.1016\/j.pharmthera.2025.108944_bb1020","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/289646a0","article-title":"Control of vascular permeability by polymorphonuclear leukocytes in inflammation","volume":"289","author":"Wedmore","year":"1981","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108944_bb1025","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/s41417-022-00531-9","article-title":"Knock-out of 5-lipoxygenase in overexpressing tumor cells-consequences on gene expression and cellular function","volume":"30","author":"Weisser","year":"2023","journal-title":"Cancer Gene Therapy"},{"issue":"4","key":"10.1016\/j.pharmthera.2025.108944_bb1030","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1164\/ajrccm\/138.4.895","article-title":"Eicosanoid production in isolated perfused lungs stimulated by calcium ionophore A23187","volume":"138","author":"Westcott","year":"1988","journal-title":"American Review of Respiratory Disease"},{"key":"10.1016\/j.pharmthera.2025.108944_bb1035","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/9781118782699.ch4","article-title":"Physiology of the ferret","author":"Whary","year":"2014","journal-title":"Biology and Diseases of the Ferret"},{"issue":"5","key":"10.1016\/j.pharmthera.2025.108944_bb1040","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/sj.bjp.0707645","article-title":"Attenuation of inflammation and cytokine production in rat colitis by a novel selective inhibitor of leukotriene A4 hydrolase","volume":"153","author":"Whittle","year":"2008","journal-title":"British Journal of Pharmacology"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108944_bb1045","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1113\/expphysiol.2007.038612","article-title":"Epoxygenases and peroxisome proliferator-activated receptors in mammalian vascular biology","volume":"93","author":"Wray","year":"2008","journal-title":"Experimental Physiology"},{"issue":"11","key":"10.1016\/j.pharmthera.2025.108944_bb1050","doi-asserted-by":"crossref","first-page":"4021","DOI":"10.1016\/j.ymthe.2024.09.005","article-title":"Targeting Rap1b signaling cascades with CDNF: Mitigating platelet activation, plasma oxylipins and reperfusion injury in stroke","volume":"32","author":"Wu","year":"2024","journal-title":"Molecular Therapy"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108944_bb1055","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3892\/etm.2024.12780","article-title":"Blockade of cysteinyl leukotriene receptor 1 alleviates asthma by inhibiting bronchial epithelial cell apoptosis and activating the Nrf2 signaling pathway","volume":"29","author":"Wu","year":"2025","journal-title":"Experimental and Therapeutic Medicine"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108944_bb1060","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1177\/19476035231169940","article-title":"Inhibition of leukotriene A4 hydrolase suppressed cartilage degradation and synovial inflammation in a mouse model of experimental osteoarthritis","volume":"15","author":"Wu","year":"2024","journal-title":"Cartilage"},{"key":"10.1016\/j.pharmthera.2025.108944_bb1065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.plefa.2017.06.008","article-title":"Genes involved in leukotriene synthesis pathway are dynamically regulated during lung development in Rhesus monkeys","volume":"122","author":"Xia","year":"2017","journal-title":"Prostaglandins, Leukotrienes, and Essential Fatty Acids"},{"key":"10.1016\/j.pharmthera.2025.108944_bb1070","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104359","article-title":"Diminished arachidonate 5-lipoxygenase perturbs phase separation and transcriptional response of Runx2 to reverse pathological ventricular remodeling","volume":"86","author":"Xie","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.pharmthera.2025.108944_bb1075","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.freeradbiomed.2021.02.034","article-title":"Inhibition of 5-lipoxygenase is associated with downregulation of the leukotriene B4 receptor 1\/ interleukin-12p35 pathway and ameliorates sepsis-induced myocardial injury","volume":"166","author":"Xie","year":"2021","journal-title":"Free Radical Biology & Medicine"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108944_bb1080","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12890-025-03534-y","article-title":"Development and validation of a Guinea pig model for concurrent allergic rhinitis and asthma using recombinant Der f 2","volume":"25","author":"Xu","year":"2025","journal-title":"BMC Pulmonary Medicine"},{"key":"10.1016\/j.pharmthera.2025.108944_bb1085","article-title":"Zileuton protects against arachidonic acid\/5-lipoxygenase\/leukotriene axis-mediated neuroinflammation in experimental traumatic brain injury","volume":"16","author":"Xu","year":"2025","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.pharmthera.2025.108944_bb1090","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101359","article-title":"5-lipoxygenase as an emerging target against age-related brain disorders","volume":"69","author":"Yan","year":"2021","journal-title":"Ageing Research Reviews"},{"issue":"7","key":"10.1016\/j.pharmthera.2025.108944_bb1095","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1172\/JCI97946","article-title":"Leukotriene receptors as potential therapeutic targets","volume":"128","author":"Yokomizo","year":"2018","journal-title":"The Journal of Clinical Investigation"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108944_bb1100","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/imr.13196","article-title":"The leukotriene B4 receptors BLT1 and BLT2 as potential therapeutic targets","volume":"317","author":"Yokomizo","year":"2023","journal-title":"Immunological Reviews"},{"key":"10.1016\/j.pharmthera.2025.108944_bb1105","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ejphar.2015.02.014","article-title":"Leukotriene C4 induces bronchoconstriction and airway vascular hyperpermeability via the cysteinyl leukotriene receptor 2 in S-hexyl glutathione-treated guinea pigs","volume":"754","author":"Yonetomi","year":"2015","journal-title":"European Journal of Pharmacology"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108944_bb1110","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/BF00918955","article-title":"Effect of prostaglandin E1 on leukotriene C4-induced increases in vascular permeability of hamster cheek pouch","volume":"16","author":"Yong","year":"1992","journal-title":"Inflammation"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108944_bb1115","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.plefa.2011.04.022","article-title":"Inhibition of 5-lipoxygenase activity in mice during cuprizone-induced demyelination attenuates neuroinflammation, motor dysfunction and axonal damage","volume":"85","author":"Yoshikawa","year":"2011","journal-title":"Prostaglandins, Leukotrienes, and Essential Fatty Acids"},{"issue":"3","key":"10.1016\/j.pharmthera.2025.108944_bb1120","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1161\/CIRCRESAHA.112.300755","article-title":"Myeloid cell 5-lipoxygenase activating protein modulates the response to vascular injury","volume":"112","author":"Yu","year":"2013","journal-title":"Circulation Research"},{"issue":"20","key":"10.1016\/j.pharmthera.2025.108944_bb1125","doi-asserted-by":"crossref","first-page":"8296","DOI":"10.1073\/pnas.0903851106","article-title":"Transcellular biosynthesis of cysteinyl leukotrienes in vivo during mouse peritoneal inflammation","volume":"106","author":"Zarini","year":"2009","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108944_bb1130","first-page":"177","article-title":"Effect of clindamycin hydrochloride on gingival crevicular fluid and immune mediators in beagles","volume":"3","author":"Zetner","year":"2002","journal-title":"Veterinary Therapeutics"},{"issue":"12","key":"10.1016\/j.pharmthera.2025.108944_bb1135","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1111\/j.1745-7254.2006.00458.x","article-title":"Cysteinyl leukotriene receptors CysLT1 and CysLT2 are upregulated in acute neuronal injury after focal cerebral ischemia in mice","volume":"27","author":"Zhang","year":"2006","journal-title":"Acta Pharmacologica Sinica"},{"issue":"17","key":"10.1016\/j.pharmthera.2025.108944_bb1140","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/j.lfs.2006.05.022","article-title":"Spatio-temporal properties of 5-lipoxygenase expression and activation in the brain after focal cerebral ischemia in rats","volume":"79","author":"Zhou","year":"2006","journal-title":"Life Sciences"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108944_bb1145","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0016-5085(87)90836-5","article-title":"In vivo production of leukotriene B4 and leukotriene C4 in rabbit colitis. Relationship to inflammation","volume":"92","author":"Zipser","year":"1987","journal-title":"Gastroenterology"},{"issue":"21","key":"10.1016\/j.pharmthera.2025.108944_bb1150","doi-asserted-by":"crossref","DOI":"10.1172\/JCI175824","article-title":"FDA modernization act 2.0: transitioning beyond animal models with human cells, organoids, and AI\/ML-based approaches","volume":"133","author":"Zushin","year":"2023","journal-title":"The Journal of Clinical Investigation"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725825001561?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725825001561?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T07:46:22Z","timestamp":1773301582000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725825001561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":230,"alternative-id":["S0163725825001561"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2025.108944","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Animal models in leukotriene research: Current insights into complex pathways and therapeutic intervention","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2025.108944","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108944"}}